MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Multiple Sclerosis (MS)
Diogenix
Attachments
Home
Parents
*Industry: Gaithersburg, Maryland
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
2011: Maryland Biotech Center awards $1.8M in grants (2011)
Architects: Diagnostics_In Vitro Diagnostics (IVD)
Architects: Multiple Sclerosis (MS)
Venture Capital: Angel, Seed & Incubator Series
Children
2013: DioGenix picks up $3.2M in search of a clearer, earlier way to diagnose multiple sclerosis_medcitynews (2013)
2014: Montgomery County doles out $500K in biotech tax credits
Blood-based Molecular Diagnostic Test for Multiple Sclerosis
DioGenix thinks it’s found a new way to identify MS patients sooner, enabling them to receive treatment sooner and potentially delay injury to the nervous system.
Gaithersburg, Maryland
Secured $3.2 million from new and existing investors including its parent company, Nerveda LLC
Jumps
*Pioneers: Multiple Sclerosis